This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Barrington's Best Stock Picks for 2011

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

AtriCure (ATRC - Get Report)

Company Profile: AtriCure is a medical device company, which develops, manufactures and sells innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue.

Current Share Price: $10.53 (Jan. 4)

Potential Upside: 36% based on a $14 price target

Barrington's Take: "We believe ATRC offers investors an appealing long-term growth story and is trading at an attractive valuation," the firm wrote. "In our opinion, there are few companies in our medical device universe that have greater growth opportunities than ATRC, which is why ATRC remains on our Best Ideas List at this point."

OraSure Technologies (OSUR)

Company Profile: OraSure Technologies develops, manufactures and markets oral fluid diagnostic products and specimen collection devices.

Current Share Price: $6.06 (Jan. 4)

Potential Upside: 39% based on a price target of $8

Barrington's Take: OraSure gets selected for addition to Barrington's Best Ideas List as the company "offers investors an aggressive growth opportunity following the culmination of over four years of very heavy R&D investment totaling over $56 million."

"We believe these shares will soon start reflecting the value of the company's new product pipeline as investors gain confidence in the company's progress toward obtaining FDA approval for its key new products," Barrington analysts wrote.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player
5 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ATRC $16.53 0.00%
BPI $6.35 0.00%
CAB $41.14 0.00%
IMAX $25.99 0.00%
LOPE $34.05 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs